CD57(+) expression in T lymphocytes has been recognized for decades as a marker of in vitro replicative senescence. In recent years, accumulating evidences have pointed on the utility of this marker to measure functional immune deficiency in patients with autoimmune disease, infectious diseases, and cancers. We review here the relevant literature and implications in clinical settings.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1189/jlb.0809566 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!